Drug Manufacture FDA Approves Lundbeck’s Rexulti for Alzheimer’s AgitationBy MohamedMis2July 25, 2023 The FDA’s recent approval of Lundbeck-Otsuka’s Rexulti marks a significant milestone in Alzheimer’s disease treatment[1]. The medication has been specifically…
